You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  Comments and Opinions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Is Benzyl Alcohol an Allergen?

Harvey Finkelstein, MD; Makolm C. Champion, MB, FRCP(C); John E. Adam, MD, FRCP(C)
Divisions of Dermatology and Gastroenterology Ottawa Civic Hospital Ottawa, Ontario K1Y 4G2 Canada

Arch Dermatol. 1985;121(6):715.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We read with interest the article by Shmunes1 in the September ARCHIVES concerning allergic dermatitis to benzyl alcohol. The author implicated 1% benzyl alcohol as a perservative in sodium tetradecyl sulfate as being the cause for the development of tender, slightly pruritic, dermal plaques at the sites of injection sclerotherapy for varicose veins. The author listed the injectable agents containing benzyl alcohol, which included vitamin preparations.

We have studied two patients with phytonadione skin hypersensitivity and find difficulty in accepting Shmunes' implication that benzyl alcohol is the allergen. This drug uses benzyl alcohol in a 0.9% concentration in the vehicle.

Report of Cases.—

A 64-year-old woman with mitral valvular heart disease had received 10 mg of phytonadione subcutaneously to reverse the effect of warfarin sodium prior to cardiac catheterization. Five days later the patient developed a pruritic erythematous indurated plaque at the site of injection. Subsequent . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.